On 60 cases of breast cancer with lymph node metastasis who received surgery in Showa University Hospital from 1994 to 1998, we investigated the relation of estrogen receptor (ER), Her-2, histological grade, multidrug resistance (MDR-1 MRP-1, MRP-2), MIB-1, topoiso melase- II, and recurrence retrospectively. On f ormalin-fixed paraffin-embedded sections, following antibody, ER, Her-2, MIB-1, MDR-1, MRP-1, MRP-2 were used for immunohistochemical staining. We investigated the recurrence value with clinical factors, MIB-1 labeling index, toppisomelase- II labeling index and expression of ER, Her-2, MRP-1. Immunohistochemically, 1.7% of cases were positive in MDR-1, 68.3% of cases were positive in MRP-1, 96.7% of cases were positive in MRP-2, respectively. An expression of MRP-1 and an increase of MIB-1 labeling index correlated with risk of recurrence. Therefore, MRP-1 was a good indicator to predict recurrence.
View full abstract